A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results.
about
Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI.Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma.Correction of arterial input function in dynamic contrast-enhanced MRI of the liverMapping of low flip angles in magnetic resonance.A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: I. SimulationsQuinacrine synergistically enhances the antivascular and antitumor efficacy of cediranib in intracranial mouse gliomaPreoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.Models and methods for analyzing DCE-MRI: a review.Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.Response-Derived Input Function Estimation for Dynamic Contrast-Enhanced MRI Demonstrated by Anti-DLL4 Treatment in a Murine U87 Xenograft Model.Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.Improving the arterial input function in dynamic contrast enhanced MRI by fitting the signal in the complex plane.A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.A unified impulse response model for DCE-MRI.Comparison of arterial input functions measured from ultra-fast dynamic contrast enhanced MRI and dynamic contrast enhanced computed tomography in prostate cancer patients.
P2860
Q34040125-81036D36-C41C-44D8-98DD-B7DC79020F03Q35863135-505AE10E-207C-4FBC-ADE8-130859EEBA18Q36020501-EE94D6B5-717A-4588-B848-6A39A6658819Q36080645-D8D4D55B-70B0-4C22-84DD-90668912C227Q36497440-CB582183-5F3B-46B4-A3EB-A379F49EFCBCQ37312695-8DB12E3F-F67E-4B4A-B59E-501389864752Q37492118-153FA96A-DB6A-4088-AAD3-894582DD8745Q38007857-EC1BAA16-E12D-4025-9042-8D61E14B7DE0Q38282639-FBB326F8-9296-477D-BD83-38A8D2C53328Q38861117-E7ADA2FE-35B6-4680-B87D-BCB0C65ABF60Q38925774-32C47917-A6A1-4929-A4A4-4F59AA08EB80Q39017777-98B0EC02-63C3-4010-A11C-41974E3E5665Q39372575-34E15EBF-CE5F-4A17-AAF0-EFDC1EC1D8C9Q40366516-98554848-2CC5-4B0E-A46A-38B4C015AF3FQ41110202-0155D093-8EC3-4755-A3C3-A757A6703F21Q44337183-ADB7A058-AC46-495E-8EFC-8BC68A887545Q47568614-A7A6C288-521C-4BE5-8120-4A16EA5640F8
P2860
A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
A model-constrained Monte Carl ...... nced MRI: II. In vivo results.
@ast
A model-constrained Monte Carl ...... nced MRI: II. In vivo results.
@en
type
label
A model-constrained Monte Carl ...... nced MRI: II. In vivo results.
@ast
A model-constrained Monte Carl ...... nced MRI: II. In vivo results.
@en
prefLabel
A model-constrained Monte Carl ...... nced MRI: II. In vivo results.
@ast
A model-constrained Monte Carl ...... nced MRI: II. In vivo results.
@en
P2093
P2860
P356
P1476
A model-constrained Monte Carl ...... anced MRI: II. In vivo results
@en
P2093
Karen L Salzman
Matthias C Schabel
Randy L Jensen
P2860
P304
P356
10.1088/0031-9155/55/16/012
P577
2010-08-03T00:00:00Z